MYUNGMOON Pharm co.,Ltd
Research MYUNGMOON Pharm co.,Ltd (017180.KS) on Bullrun: market cap KRW 44.45B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker017180.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 44.45B
- Financial periodQ2 2026
- RevenueKRW 51.21B
- Net income-KRW 1.26B
- Free cash flow-KRW 4.19B
- Gross margin57.9%
Valuation Snapshot
latest market cap is KRW 44.45B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 44.45B | n/a | n/a | n/a |
About MYUNGMOON Pharm co.,Ltd
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally.
Related stock research
Other Healthcare stocks
Dongwha Pharm.Co.,Ltd (000020.KS)
Yuhan Corporation (000100.KS)
Yuyu Pharma, Inc. (000220.KS)
Ildong Holdings Co., Ltd. (000230.KS)
Samil Pharmaceutical Co.,Ltd (000520.KS)
Dong-A Socio Holdings Co., Ltd. (000640.KS)
JW Pharmaceutical Corporation (001060.KS)
SAMSUNG PHARM. Co., LTD. (001360.KS)
Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ)
Chong Kun Dang Holdings Corp. (001630.KS)
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
HANDOK Inc. (002390.KS)
Frequently asked questions
What is MYUNGMOON Pharm co.,Ltd's market cap?
MYUNGMOON Pharm co.,Ltd's market capitalization is KRW 44.45B.
What does MYUNGMOON Pharm co.,Ltd do?
MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally.